Proposed payment cuts to Medicare Advantage (MA) could cause many beneficiaries to lose access to MA plans and cause great disruption to the market, according to a new report by Oliver Wyman for America's Health Insurance Plans.
Proposed payment cuts to Medicare Advantage (MA) could cause many beneficiaries to lose access to MA plans and cause great disruption to the market, according to a new report by Oliver Wyman for America’s Health Insurance Plans (AHIP).
Proposed payment policies in combination with the phase-in of cuts under the Affordable Care Act and other legislative and regulatory cuts will mean a 1.2% reduction in payments to MA plans in 2016, the report found. This reduction even takes into account 1.7% and 0.2% increases from both the ratebook change and the change in plans’ Star ratings for 2016, respectively.
After calculating a range of potential outcomes, Oliver Wyman determined that monthly premiums or benefit changes per member could be as much as $20, which can be a significant burden for the 37% of MA enrollees with annual incomes below $20,000.
“The potential for higher premiums and reduced benefits could result in a significant amount of upheaval in the MA market that will likely affect virtually all of the approximately 16 million Medicare beneficiaries enrolled in [MA organizations],” according to the report.
Some of the expected upheaval includes potential plan exits, reduction sin service areas, and reduced MA enrollment as plan value declines from 2014 to 2016. AHIP and Oliver Wyman expect that individuals who are more likely to need medical services will be adversely affected if they are forced out of MA into Medicare fee-for-service, which lacks coordinated care.
“Over the last two years, Medicare Advantage rates have been cut by approximately ten percent,” AHIP President and Chief Executive Officer Karen Ignagni said in a statement. “Another cut this year would jeopardize the care coordination and benefits upon which millions of seniors rely. We urge CMS to protect beneficiaries from any further disruption and provide stability to the coverage they depend on.”
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More